Moderna Inc. Stock Advances 8.9%, Outperforms Peers
Dow Jones2026/08/21 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. rose 8.9% to $145.13 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.
Moderna Inc. closed 17.8% below its 52-week high of $176.66, which the company reached on August 19th.
The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.24, Pfizer Inc. rose 1.0% to $28.07, and Gilead Sciences Inc. rose 1.87% to $146.12.
Trading volume totaled 86.7 million, compared to the 50-day average of 13.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 21, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Sui crypto surges 14% – Why traders must watch $1.05 closely
Japanese Yen: Policy delay risks weakness against US Dollar - Commerzbank
IMF: Global debt will exceed GDP in 2029
The latest forecast from the IMF shows that global public debt will exceed 100% of GDP by 2029, two years earlier than previously expected. The IMF Managing Director issued a rare warning, specifically naming the United States’ debt path as “unsustainable” and pointing out that fiscal consolidation in various countries is seriously lagging. What's even more dangerous is that persistent inflation may force the Federal Reserve to continue raising interest rates, increasing financing costs and creating a vicious cycle of "high debt—high interest rates—even higher debt."
Crypto prices
More
